Promomed Group presented plans for the development of biotechnologies to Dmitry Chernyshenko, Deputy Chairman of the Government of the Russian Federation

On October 22, 2021, Dmitry Chernyshenko, Deputy Prime Minister of the Russian Federation, paid a working visit to enterprises and infrastructure facilities of the Mordovian Republic. During the meeting at the Faculty of Biotechnology and Biology of the Ogarev Mordovian State University, Promomed Group presented plans for the development of biotechnologies in the pharmaceutical industry on the basis of its production site, Biochemist JSC, as well as a project to create the Mordovian Federal Biotechnology Development Center.

"There is already a significant groundwork in the region for potential leadership in the field of biomedical technologies: a powerful scientific potential is at the University. Ogareva, research — at the Promomed Group development center, industrial — at the Biochemist plant. Mordovia has every chance to build a world-class biotech cluster and make Russia one of the leaders in innovative pharmaceuticals. Promomed Group is ready to act as an industrial partner of such a project," commented Peter Bely, Chairman of the Board of Directors of Promomed Group.

When asked by the Deputy Prime Minister about current developments, Kira Zaslavskaya, Director of New Products at Promomed Group, gave an example of a drug based on RNA technologies. "We have managed to develop a full-cycle production technology from the producer strain to the finished dosage form. At the same time, it was important to achieve not only high productivity of the strain, but also to develop a complex system for isolating and purifying the active substance, preventing its destruction. The biotechnological nature of the drug required the development of unique methods for monitoring biological activity," said Kira Zaslavskaya.

"The development of biotech in Russia is socially and scientifically significant. Successes in this area will reduce the burden on the medical and social security system due to the emergence of effective innovative therapies for the most significant and dangerous diseases. In addition, it will give an impetus to the development of science, increase export potential, and promote the development of related fields, from food production to digital technologies," said Petr Bely.

The company plans to develop the field of biotechnology and create new-generation drugs in its own laboratories that meet critical challenges to life and health.